Medicamen Biotech Limited

NSEI:MEDICAMEQ Stock Report

Market Cap: ₹5.6b

Medicamen Biotech Balance Sheet Health

Financial Health criteria checks 4/6

Medicamen Biotech has a total shareholder equity of ₹2.2B and total debt of ₹201.7M, which brings its debt-to-equity ratio to 9.3%. Its total assets and total liabilities are ₹2.9B and ₹726.0M respectively. Medicamen Biotech's EBIT is ₹115.6M making its interest coverage ratio 3.3. It has cash and short-term investments of ₹64.2M.

Key information

9.3%

Debt to equity ratio

₹201.68m

Debt

Interest coverage ratio3.3x
Cash₹64.15m
Equity₹2.16b
Total liabilities₹725.97m
Total assets₹2.89b

Recent financial health updates

These 4 Measures Indicate That Medicamen Biotech (NSE:MEDICAMEQ) Is Using Debt Extensively

Jul 04
These 4 Measures Indicate That Medicamen Biotech (NSE:MEDICAMEQ) Is Using Debt Extensively

Recent updates

Medicamen Biotech Limited's (NSE:MEDICAMEQ) P/S Is Still On The Mark Following 41% Share Price Bounce

Sep 28
Medicamen Biotech Limited's (NSE:MEDICAMEQ) P/S Is Still On The Mark Following 41% Share Price Bounce

Medicamen Biotech (NSE:MEDICAMEQ) Will Pay A Dividend Of ₹1.00

Sep 03
Medicamen Biotech (NSE:MEDICAMEQ) Will Pay A Dividend Of ₹1.00

Medicamen Biotech (NSE:MEDICAMEQ) Is Due To Pay A Dividend Of ₹1.00

Aug 16
Medicamen Biotech (NSE:MEDICAMEQ) Is Due To Pay A Dividend Of ₹1.00

These 4 Measures Indicate That Medicamen Biotech (NSE:MEDICAMEQ) Is Using Debt Extensively

Jul 04
These 4 Measures Indicate That Medicamen Biotech (NSE:MEDICAMEQ) Is Using Debt Extensively

What Medicamen Biotech Limited's (NSE:MEDICAMEQ) 28% Share Price Gain Is Not Telling You

May 21
What Medicamen Biotech Limited's (NSE:MEDICAMEQ) 28% Share Price Gain Is Not Telling You

More Unpleasant Surprises Could Be In Store For Medicamen Biotech Limited's (NSE:MEDICAMEQ) Shares After Tumbling 26%

Mar 17
More Unpleasant Surprises Could Be In Store For Medicamen Biotech Limited's (NSE:MEDICAMEQ) Shares After Tumbling 26%

Medicamen Biotech (NSE:MEDICAMEQ) Will Pay A Dividend Of ₹1.00

Sep 13
Medicamen Biotech (NSE:MEDICAMEQ) Will Pay A Dividend Of ₹1.00

Why Medicamen Biotech's (NSE:MEDICAMEQ) Shaky Earnings Are Just The Beginning Of Its Problems

Nov 19
Why Medicamen Biotech's (NSE:MEDICAMEQ) Shaky Earnings Are Just The Beginning Of Its Problems

There's Reason For Concern Over Medicamen Biotech Limited's (NSE:MEDICAMEQ) Price

Dec 03
There's Reason For Concern Over Medicamen Biotech Limited's (NSE:MEDICAMEQ) Price

Financial Position Analysis

Short Term Liabilities: MEDICAMEQ's short term assets (₹1.6B) exceed its short term liabilities (₹688.0M).

Long Term Liabilities: MEDICAMEQ's short term assets (₹1.6B) exceed its long term liabilities (₹38.0M).

Debt to Equity History and Analysis

Debt Level: MEDICAMEQ's net debt to equity ratio (6.4%) is considered satisfactory.

Reducing Debt: MEDICAMEQ's debt to equity ratio has increased from 4.5% to 9.3% over the past 5 years.

Debt Coverage: MEDICAMEQ's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: MEDICAMEQ's interest payments on its debt are well covered by EBIT (3.3x coverage).

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y